 |
|
Molecular Profiling and the Identification of Genes Associated With Metastatic Oral Cavity/Pharynx Squamous Cell Carcinoma
Cecelia E. Schmalbach, MD, MS;
Douglas B. Chepeha, MD, MSPH;
Thomas J. Giordano, MD, PhD;
Mark A. Rubin, MD;
Theodoros N. Teknos, MD;
Carol R. Bradford, MD;
Gregory T. Wolf, MD;
Rork Kuick, MS;
David E. Misek, PhD;
Douglas K. Trask, MD, PhD;
Samir Hanash, MD, PhD
Arch Otolaryngol Head Neck Surg. 2004;130:295-302.
Objective To investigate differences in gene expression profiles between oral cavity/oropharynx squamous cell carcinoma (OC/OP SCC) primary tumors that have metastasized to cervical lymph nodes and nonmetastatic OC/OP SCC tumors.
Design Oligonucleotide microarray analysis of primary tumors was used to produce gene expression profiles. Profile comparisons between metastatic and nonmetastatic tumors were performed using principal component analysis, t test, and fold change differences. A similar comparison between metastatic tumors and noncancer oral mucosa samples was performed to ensure tumor origin.
Subjects A prospective cohort of 20 patients with previously untreated OC/OP SCC who underwent pathologic staging following surgical resection and lymphadenectomy.
Results Of the approximately 9600 genes profiled, 101 demonstrated significant expression differences between the metastatic and nonmetastatic tumors (fold change  1.5; P<.01). Among this subset, 57 genes also exhibited significant differences between metastatic tumors and normal mucosa samples (fold change 1.5; P<.05). This profile included genes related to the extracellular matrix, adhesion, motility, inflammation, and protease inhibition. Collagen type 11  -1 (COL11A1) demonstrated the greatest differential expression between metastatic and nonmetastatic OC/OP SCC tumors (fold change = 7.61; P = .002). Tissue inhibitor of metalloproteinase 1 (TIMP-1) also demonstrated increased expression in metastatic tumors (fold change = 3.3; P = .003).
Conclusions Metastatic OC/OP SCC has a distinct gene expression profile compared with nonmetastatic OC/OP SCC and normal oral mucosa. This metastatic profile includes genes related to the extracellular matrix, adhesion, motility, and protease inhibition. Knowledge gained through tumor gene expression profiling may facilitate early detection of aggressive tumors and targeted therapeutic interventions.
From the Departments of Otolaryngology–Head and Neck Surgery (Drs Schmalbach, Chepeha, Teknos, Bradford, and Wolf), Pathology (Drs Giordano and Rubin), and Pediatrics (Mr Kuick and Drs Misek and Hanash), University of Michigan Medical School, Ann Arbor; and Department of Otolaryngology–Head and Neck Surgery, University of Iowa, Iowa City (Dr Trask). The authors have no relevant financial interest in this article.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Examination of Oral Cancer Biomarkers by Tissue Microarray Analysis
Choi et al.
Arch Otolaryngol Head Neck Surg 2008;134:539-546.
ABSTRACT
| FULL TEXT
Maintenance of Head and Neck Tumor Gene Expression Profiles upon Lymph Node Metastasis
Roepman et al.
Cancer Res. 2006;66:11110-11114.
ABSTRACT
| FULL TEXT
RhoC GTPase Expression as a Potential Marker of Lymph Node Metastasis in Squamous Cell Carcinomas of the Head and Neck
Kleer et al.
Clin. Cancer Res. 2006;12:4485-4490.
ABSTRACT
| FULL TEXT
Molecular biology of squamous cell carcinoma of the head and neck.
Perez-Ordonez et al.
J. Clin. Pathol. 2006;59:445-453.
ABSTRACT
| FULL TEXT
Signaling and Transcriptional Changes Critical for Transformation of Human Cells by Simian Virus 40 Small Tumor Antigen or Protein Phosphatase 2A B56{gamma} Knockdown
Moreno et al.
Cancer Res. 2004;64:6978-6988.
ABSTRACT
| FULL TEXT
|
